Application Notes & Case Studies

  1. Advanced ePRO Tools Enable A Global CRO To Expand Its Service Offerings 9/22/2022

    In this case study, discover how a Technology Enablement Model allowed a CRO to transition to full ePRO deployment ownership in three stages.

  2. Preparing A New Drug Application (NDA) With A CDISC Conversion 9/21/2022

    Regulatory submissions are the most critical milestones in clinical research programs. Learn how quality submissions can accelerate time to market, maximize research investments and bring the benefit of new treatments to patients sooner.

  3. Regulatory Approval For Novel Device Achieved With Comprehensive Clinical Data Management 9/21/2022

    In this case study, find out how data capture and management activities, programming, and medical writing for a clinical study report were supported to solve the major diagnostic challenge of distinguishing between bacterial and viral infections.

  4. Automated Data Capture To Train An AI Algorithm With eSource 9/20/2022

    Discover why an AI algorithm needs a steady and significant stream of data to become more accurate and prove its efficacy in a clinical setting.

  5. How A Remote ePRO Solution Helped Reduce Patient Burden 9/19/2022

    Discover how transitioning multiple studies from on-site to at-home assessments improved patient retention and recruitment for a global neurology program.

  6. Predictors Of Severe CRS In Longitudinal CAR T-Cell Clinical Trial Data 9/15/2022

    Cytokine release syndrome (CRS) is a life-threatening toxicity of chimeric antigen receptor (CAR) T-cell therapy and there is a limited understanding of its risk factors. Find out how laboratory tests were analyzed with repeated measurements to identify differences in trends that persist across a variety of study designs, sponsors, and indications.

  7. Optimizing Choice, Flexibility And Outcomes With Patient-First Data Collection For Oncology 9/14/2022

    Oncology trials placed a heavy burden on patients due to travel burden, poor patient experience and multi-year clinical trial commitments. Sites also struggle with cancer trials due to enrollment delays, complex data workflows, and multiple amendments requiring re-consents. Today, there is a more effective, patient-first solution.

  8. TargetCancer Foundation Successfully Engages And Empowers Rare Cancer Patients with Medrio 9/13/2022

    Explore how TargetCancer Foundation implemented Medrio’s remote consent function in their TCF-001 TRACK study, which has an objective to determine if rare tumors can benefit from matched molecular therapy.

  9. Optimizing Direct-To-Patient Supply Management: ClinChoice And 89Bio 9/1/2022

    Learn how the CRO ClinChoice and the sponsor 89Bio were conducting a phase II, randomized, double-blind, placebo-controlled study that needed to pivot to a decentralized protocol during the pandemic or face trial disruption.

  10. The Largest Parkinson’s Disease Study Ever Attempted Is Being Made Possible Only With Mobile Research Nurses 8/25/2022

    The Trial of Parkinson’s and Zoledronic acid (TOPAZ) is seeking to enroll 3,500 participants over the age of 60, making it the largest double-blind, placebo-controlled, randomized clinical trial ever attempted in people with parkinsonism. Find out the approaches taken and the results in this case study.